vs
Side-by-side financial comparison of Varex Imaging Corp (VREX) and Vroom, Inc. (VRM). Click either name above to swap in a different company.
Vroom, Inc. is the larger business by last-quarter revenue ($235.9M vs $209.6M, roughly 1.1× Varex Imaging Corp). Varex Imaging Corp runs the higher net margin — 1.1% vs -59.8%, a 60.9% gap on every dollar of revenue. On growth, Vroom, Inc. posted the faster year-over-year revenue change (12.9% vs 4.9%). Varex Imaging Corp produced more free cash flow last quarter ($-26.8M vs $-108.8M). Over the past eight quarters, Varex Imaging Corp's revenue compounded faster (0.8% CAGR vs -49.5%).
Varex Imaging Corp is a global supplier of advanced imaging components and solutions, including X-ray tubes, digital flat panel detectors, and image processing software. Its products serve medical imaging, radiation oncology, and industrial non-destructive testing segments, with customers across key global markets.
Vroom, Inc. is a parent company of United Auto Credit Corporation (UACC) and CarStory. Previously, Vroom was a used car retailer and e-commerce company that let consumers buy, sell, and finance cars online. Vroom ceased e-commerce automotive sales operations on January 22, 2024.
VREX vs VRM — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2023
| Metric | | |
|---|---|---|
| Revenue | $209.6M | $235.9M |
| Net Profit | $2.3M | $-141.1M |
| Gross Margin | 33.3% | 12.3% |
| Operating Margin | 7.3% | -11.5% |
| Net Margin | 1.1% | -59.8% |
| Revenue YoY | 4.9% | 12.9% |
| Net Profit YoY | 866.7% | -669.8% |
| EPS (diluted) | $0.05 | $-80.66 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $209.6M | — | ||
| Q4 25 | $228.9M | — | ||
| Q3 25 | $203.0M | — | ||
| Q2 25 | $212.9M | — | ||
| Q1 25 | $199.8M | — | ||
| Q3 24 | $205.7M | — | ||
| Q2 24 | $209.1M | — | ||
| Q1 24 | $206.2M | — |
| Q1 26 | $2.3M | — | ||
| Q4 25 | $12.2M | — | ||
| Q3 25 | $-89.1M | — | ||
| Q2 25 | $6.9M | — | ||
| Q1 25 | $-300.0K | — | ||
| Q3 24 | $-51.1M | — | ||
| Q2 24 | $1.4M | — | ||
| Q1 24 | $1.4M | — |
| Q1 26 | 33.3% | — | ||
| Q4 25 | 34.0% | — | ||
| Q3 25 | 33.3% | — | ||
| Q2 25 | 36.0% | — | ||
| Q1 25 | 34.3% | — | ||
| Q3 24 | 32.6% | — | ||
| Q2 24 | 32.0% | — | ||
| Q1 24 | 31.9% | — |
| Q1 26 | 7.3% | — | ||
| Q4 25 | 8.6% | — | ||
| Q3 25 | -39.8% | — | ||
| Q2 25 | 10.4% | — | ||
| Q1 25 | 5.6% | — | ||
| Q3 24 | 5.3% | — | ||
| Q2 24 | 4.4% | — | ||
| Q1 24 | 3.7% | — |
| Q1 26 | 1.1% | — | ||
| Q4 25 | 5.3% | — | ||
| Q3 25 | -43.9% | — | ||
| Q2 25 | 3.2% | — | ||
| Q1 25 | -0.2% | — | ||
| Q3 24 | -24.8% | — | ||
| Q2 24 | 0.7% | — | ||
| Q1 24 | 0.7% | — |
| Q1 26 | $0.05 | — | ||
| Q4 25 | $0.29 | — | ||
| Q3 25 | $-2.15 | — | ||
| Q2 25 | $0.17 | — | ||
| Q1 25 | $-0.01 | — | ||
| Q3 24 | $-1.25 | — | ||
| Q2 24 | $0.03 | — | ||
| Q1 24 | $0.03 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $125.6M | $135.6M |
| Total DebtLower is stronger | $367.6M | $454.2M |
| Stockholders' EquityBook value | $476.9M | $127.7M |
| Total Assets | $1.1B | $1.5B |
| Debt / EquityLower = less leverage | 0.77× | 3.56× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $125.6M | — | ||
| Q4 25 | $155.1M | — | ||
| Q3 25 | $152.6M | — | ||
| Q2 25 | $223.0M | — | ||
| Q1 25 | $212.6M | — | ||
| Q3 24 | $200.5M | — | ||
| Q2 24 | $190.0M | — | ||
| Q1 24 | $188.9M | — |
| Q1 26 | $367.6M | — | ||
| Q4 25 | $367.5M | — | ||
| Q3 25 | $367.5M | — | ||
| Q2 25 | $567.2M | — | ||
| Q1 25 | $567.0M | — | ||
| Q3 24 | $443.4M | — | ||
| Q2 24 | $443.1M | — | ||
| Q1 24 | $442.9M | — |
| Q1 26 | $476.9M | — | ||
| Q4 25 | $472.6M | — | ||
| Q3 25 | $455.3M | — | ||
| Q2 25 | $549.7M | — | ||
| Q1 25 | $540.2M | — | ||
| Q3 24 | $529.1M | — | ||
| Q2 24 | $581.2M | — | ||
| Q1 24 | $576.1M | — |
| Q1 26 | $1.1B | — | ||
| Q4 25 | $1.1B | — | ||
| Q3 25 | $1.1B | — | ||
| Q2 25 | $1.4B | — | ||
| Q1 25 | $1.3B | — | ||
| Q3 24 | $1.2B | — | ||
| Q2 24 | $1.3B | — | ||
| Q1 24 | $1.3B | — |
| Q1 26 | 0.77× | — | ||
| Q4 25 | 0.78× | — | ||
| Q3 25 | 0.81× | — | ||
| Q2 25 | 1.03× | — | ||
| Q1 25 | 1.05× | — | ||
| Q3 24 | 0.84× | — | ||
| Q2 24 | 0.76× | — | ||
| Q1 24 | 0.77× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-16.1M | $-108.1M |
| Free Cash FlowOCF − Capex | $-26.8M | $-108.8M |
| FCF MarginFCF / Revenue | -12.8% | -46.1% |
| Capex IntensityCapex / Revenue | 5.1% | 0.3% |
| Cash ConversionOCF / Net Profit | -7.00× | — |
| TTM Free Cash FlowTrailing 4 quarters | $-13.3M | $-536.3M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $-16.1M | — | ||
| Q4 25 | $7.9M | — | ||
| Q3 25 | $7.7M | — | ||
| Q2 25 | $16.6M | — | ||
| Q1 25 | $9.5M | — | ||
| Q3 24 | $25.9M | — | ||
| Q2 24 | $8.0M | — | ||
| Q1 24 | $3.1M | — |
| Q1 26 | $-26.8M | — | ||
| Q4 25 | $2.3M | — | ||
| Q3 25 | $1.4M | — | ||
| Q2 25 | $9.8M | — | ||
| Q1 25 | $5.3M | — | ||
| Q3 24 | $19.9M | — | ||
| Q2 24 | $3.3M | — | ||
| Q1 24 | $-2.7M | — |
| Q1 26 | -12.8% | — | ||
| Q4 25 | 1.0% | — | ||
| Q3 25 | 0.7% | — | ||
| Q2 25 | 4.6% | — | ||
| Q1 25 | 2.7% | — | ||
| Q3 24 | 9.7% | — | ||
| Q2 24 | 1.6% | — | ||
| Q1 24 | -1.3% | — |
| Q1 26 | 5.1% | — | ||
| Q4 25 | 2.4% | — | ||
| Q3 25 | 3.1% | — | ||
| Q2 25 | 3.2% | — | ||
| Q1 25 | 2.1% | — | ||
| Q3 24 | 2.9% | — | ||
| Q2 24 | 2.2% | — | ||
| Q1 24 | 2.8% | — |
| Q1 26 | -7.00× | — | ||
| Q4 25 | 0.65× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 2.41× | — | ||
| Q1 25 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 5.71× | — | ||
| Q1 24 | 2.21× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
VREX
| Medical Segment | $144.8M | 69% |
| Industrial Segment | $64.8M | 31% |
VRM
Segment breakdown not available.
